Commvault Systems Inc. (Commvault) is a technology company that offers solutions for data protection, information management software applications, and related services.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Commvault's R&D is engaged in the design, development, testing, and certification of a cyber resilience platform and solutions. The company's engineering efforts support product development across major operating systems, databases, applications, hyperscalers, and network storage devices. A significant portion of development efforts is dedicated to certification, integration, and support to ensure interoperability with strategic partners' solutions. The company has also invested in automating product testing and quality assurance laboratories. The principal R&D unit of the company is located at the corporate headquarters in Tinton Falls, New Jersey. This unit is responsible for managing the company's R&D activities, which include the development of new offerings and applications, the modification of existing ones, and ensuring the design, certification, and testing of offerings. The unit also handles legal costs associated with patent registration. In FY2025, the company incurred expenses of US$146.3 million on R&D, which, as a percentage of revenue, stood at 15%.